(Q43761885)

26 November 2017

title

Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience (English)

1 reference

26 November 2017

1 reference

12

1 reference

26 November 2017

David H McKenna

1

1 reference

26 November 2017

Darin Sumstad

2

1 reference

26 November 2017

Nancy Bostrom

3

1 reference

26 November 2017

Diane M Kadidlo

4

1 reference

26 November 2017

Susan Fautsch

5

1 reference

26 November 2017

Sarah McNearney

6

1 reference

26 November 2017

Rose Dewaard

7

1 reference

26 November 2017

Philip B McGlave

8

1 reference

26 November 2017

Daniel J Weisdorf

9

1 reference

26 November 2017

John E Wagner

10

1 reference

26 November 2017

Jeffrey McCullough

11

1 reference

26 November 2017

publication date

1 March 2007

1 reference

26 November 2017

1 reference

26 November 2017

volume

47

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

520-528

1 reference

The biology of natural killer cells and implications for therapy of human disease

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

Biology of natural killer cells in cancer and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

Natural killer cells and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

The Minnesota Molecular and Cellular Therapeutics Facility: a state-of-the-art biotherapeutics engineering laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

HPC viability measurement: trypan blue versus acridine orange and propidium iodide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

IL-2-activated murine newborn liver NK cells enhance engraftment of hematopoietic stem cells in MHC-mismatched recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

Use of natural killer cells in hematopoetic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01145.X

10.1111/J.1537-2995.2006.01145.X

21 January 2018

Identifiers

DOI

1 reference

release_s2sqsnkeuzcutlljic7w4hkjdq

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s2sqsnkeuzcutlljic7w4hkjdq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference